primary antibodies against proliferating cell nuclear antigen (pcna) (Thermo Fisher)
Structured Review

Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway"
Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
Journal: Open Medicine
doi: 10.1515/med-2023-0687
Figure Legend Snippet: Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Techniques Used: CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Expressing, Western Blot
Figure Legend Snippet: The effects of circ_0113656 on ox-LDL-induced HVSMC injury. (a) Circ_0113656 expression was detected by qRT-PCR in the blood samples of AS patients and healthy volunteers ( N = 17 and N = 13, respectively). (b) Circ_0113656 expression was detected by qRT-PCR in HVSMCs treated with ox-LDL (0, 25, 50, and 100 µg/mL). (c and d) The circular structure of circ_0113656 was identified by using RNase R, random primers, and oligo(dT) 18 primers. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, and ox-LDL + si-circ_0113656 group, with untreated HVSMCs as controls, and circ_0113656 expression was analyzed by qRT-PCR (e), cell viability by CCK-8 (f), cell proliferation by EdU assay (g), cell invasion by transwell assay (h), cell migration by wound-healing assay (i), and the protein expression of PCNA and MMP2 by Western blotting analysis (j). ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Techniques Used: Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot
Figure Legend Snippet: The effects of circ_0113656 knockdown and miR-188-3p depletion on ox-LDL-induced HVSMC injury. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, ox-LDL + si-circ_0113656 group, ox-LDL + si-circ_0113656 + anti-miR-NC group, and ox-LDL + si-circ_0113656 + anti-miR-188-3p group, with untreated HVSMCs as controls. MiR-188-3p expression was analyzed by qRT-PCR (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Techniques Used: Knockdown, Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot
Figure Legend Snippet: The effects of miR-188-3p and IGF2 on ox-LDL-induced HVSMC disorders. HVSMCs were divided into the ox-LDL group, ox-LDL + miR-NC group, ox-LDL + miR-188-3p group, ox-LDL + miR-188-3p + pcDNA group, and ox-LDL + miR-188-3p + IGF2 group, with mock HVSMCs as controls. IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Techniques Used: Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay
Figure Legend Snippet: The effects of IGF2 overexpression on HVSMC phenotypes. HVSMCs were transfected with pcDNA or the overexpression plasmid of IGF2, and IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d), cell migration by wound-healing assay (e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). ** P < 0.01, and *** P < 0.001.
Techniques Used: Over Expression, Transfection, Plasmid Preparation, Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay
